BiotechTube
Home/Pipeline/Osteoarthritis Treatment Program

Osteoarthritis Treatment Program

Osteoarthritis

Pre-clinicalActive

Key Facts

Indication
Osteoarthritis
Phase
Pre-clinical
Status
Active
Company
Biovico

About Biovico

Biovico is a Warsaw-based, private biotechnology and pharmaceutical company with a 15-year history, operating in diagnostics and digital health. It is developing a pipeline of innovative solutions, with a pronounced focus on osteoarthritis and regenerative medicine, utilizing platforms like biocellulose-based biomaterials and hyaluronic acid. The company appears to be in a pre-revenue, research and development stage, aiming to address significant unmet medical needs in joint health and beyond through its paradigm-shifting approach.

View full company profile

Therapeutic Areas

OsteoarthritisJoint HealthRegenerative Medicine

Other Osteoarthritis Drugs

DrugCompanyPhase
MSC‑OAAdvancellsPhase 1
Osteoarthritis programRisen Pharma TechClinical (China & US)
ViscoCell™ for OsteoarthritisLikardaPre-clinical
Osteoarthritis Biologic TherapyAgeless BiotechPhase 2b
PKM-011PK MEDPre-clinical
CYT-108CytonicsPhase 2
Topical PSGAGADORA Life SciencePre-clinical
FGF18 Gene TherapyRemedium BioPre-clinical
MOTYS™Doron TherapeuticsPhase 3
aGFScarcell TherapeuticsPhase 1
Cartilage RepairSayenza BiosciencesClinical
BRM521BRIM BiotechnologyPreclinical